Computerized community cholesterol control (4C): Meeting the challenge of secondary prevention

Harel Gilutz, Lena Novack, Pesach Shvartzman, Julian Zelingher, Dan Y. Bonneh, Yaakov Henkin, Maximo Maislos, Roni Peleg, Zvis Liss, Gab Rabinowitz, Daniel Vardy, Doron Zahger, Reuven Ilia, Niki Leibermann, Avi Porath

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Background: Dyslipidemia remains underdiagnosed and undertreated in patients with coronary artery disease. The Computer-based Clinical Decision Support System provides an opportunity to close these gaps. Objectives: To study the impact of computerized intervention on secondary prevention of CAD. Methods: The CDSS was programmed to automatically detect patients with CAD and to evaluate the availability of an updated lipoprotein profile and treatment with lipid-lowering drugs. The program produced automatic computer-generated monitoring and treatment recommendations. Adjusted primary clinics were randomly assigned to intervention (n=56) or standard care arms (n=56). Reminders were mailed to the primary medical teams in the intervention arm every 4 months updating them with current lipid levels and recommendations for further treatment. Compliance and lipid levels were monitored. The study group comprised all patients with CAD who were alive at least 3 months after hospitalization. Results: Follow-up was available for 7448 patients (median 19.8 months, range 6-36 months). Overall, 51.7% of patients were adequately screened, and 55.7% of patients were compliant with treatment to lower lipid level. In patients with initial low density lipoprotein > 120 mg/dl, a significant decrease in LDL levels was observed in both arms, but was more pronounced in the intervention arm: 121.9 ± 34.2 vs. 124.3 ± 34.6 mg/dl (P <0.02). A significantly lower rate of cardiac rehospitalizations was documented in patients who were adequately treated with lipid-lowering drugs, 37% vs. 40.9% (P < 0.001). Conclusions: This initial assessment of our data represent a real-world snapshot where physicians and CAD patients often do not adhere to clinical guidelines, presenting a major obstacle to implementing effective secondary prevention. Our automatic computerized reminders system substantially facilitates adherence to guidelines and supports wide-range implementation.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalIsrael Medical Association Journal
Volume11
Issue number1
StatePublished - 16 Jun 2009

Keywords

  • Compliance
  • Computerized reminders
  • Dyslipidemia
  • Secondary prevention
  • Treatment gap

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Computerized community cholesterol control (4C): Meeting the challenge of secondary prevention'. Together they form a unique fingerprint.

Cite this